Aspects thérapeutiques des neuropathies dysimmunes chroniques

1991, Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP), Neurology, 41, 617, 10.1212/WNL.41.5.617 Dalakas, 1981, Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment, Ann Neurol, 9, 134, 10.1002/ana.410090719 Dalakas, 2009, Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy, Ann Neurol, 65, 286, 10.1002/ana.21577 Delmont, 2006, Multifocal motor neuropathy with and without conduction block: a single entity?, Neurology, 67, 592, 10.1212/01.wnl.0000234063.51897.20 Dyck, 1982, Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment, Ann Neurol, 11, 136, 10.1002/ana.410110205 Dyck, 1994, A Plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy, Ann Neurol, 36, 838, 10.1002/ana.410360607 Eftimov, 2009, Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy, Cochrane Database Syst Rev, 10.1002/14651858.CD001797.pub2 Hahn, 1996, Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. A double blind, sham-controlled, crossover study, Brain, 119, 1055, 10.1093/brain/119.4.1055 Hughes, 2001, Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy, Ann Neurol, 50, 195, 10.1002/ana.1088 Hughes, 2008, Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial, Lancet Neurol, 7, 136, 10.1016/S1474-4422(07)70329-0 Hughes, 2010, Intramuscular interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy, Neurology, 74, 651, 10.1212/WNL.0b013e3181d1a862 Hughes, 2009, Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy, Cochrane Database Syst Rev Lopate, 2005, Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone, Arch. Neurol, 62, 249, 10.1001/archneur.62.2.249 Lunn, 2008, Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies, Cochrane Database Syst Rev McCrone, 2003, Costutility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy, Eur J Neurol, 10, 687, 10.1046/j.1351-5101.2003.00701.x Mehndiratta, 2008, Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy (Review), Cochrane Database Syst Rev Mehndiratta, 2008, Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy, Cochrane Database Syst Rev Piepers, 2007, Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial, Brain, 130, 2004, 10.1093/brain/awm144 2009, Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study, Lancet Neurol, 8, 158, 10.1016/S1474-4422(08)70299-0 2008, Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy, J Neurol Neurosurg Psychiatry, 79, 115 Umapathi, 2009, Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy, Cochrane Database Syst Rev, 10.1002/14651858.CD003217.pub3 Van den Bergh, 2010, Eur J Neurol, 17, 356, 10.1111/j.1468-1331.2009.02930.x Van Schaik, 2009, Intravenous immunoglobulin for multifocal motor neuropathy, Cochrane Database Syst Rev Verschueren, 2005, Lewis-Sumner syndrome and multifocal motor neuropathy, Muscle Nerve, 31, 88, 10.1002/mus.20236 Viala, 2004, Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome, Brain, 127, 2010, 10.1093/brain/awh222